Loading data for COR — first visit, this takes a few seconds.
Cencora Inc. (COR)
NYSE: COR
· Real-Time Price · USD
328.06
+4.29 (1.33%)
At close: Aug 25, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Cencora Inc. (COR) Stock Price, Analysis & Data
1.33% (1D)
No data available
| Bid | 326.76 |
| Market Cap | 62.6B |
| Revenue (ttm) | 332.77B |
| Net Income (ttm) | 2.62B |
| 0.57 | |
| 13.47 | |
| 24.35 | |
| 16.58 | |
| P/B (ttm) | 20.52 |
| P/S (ttm) | 0.19 |
| Earnings Date | Nov 4, 2026 |
| Ask | 337.77 |
| Volume | 1,086,395 |
| Avg. Volume (20D) | 1,517,828 |
| Open | 322.68 |
| Previous Close | 323.77 |
| Day's Range | 321.43 - 328.50 |
| 52-Week Range | 244.82 - 377.54 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $2.4 (0.74%) |
| Ex-Dividend Date | Aug 14, 2026 |
About COR
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alt...
Industry Medical Distribution
Sector Healthcare
IPO Date Apr 4, 1995
Employees 47,000
Stock Exchange NYSE
Ticker Symbol COR
Website https://www.cencora.com
Financial Performance
In 2025, Cencora's revenue was 321.33B, an increase of 9.31% compared to the previous year's 293.96B. Earnings were 1.55B, an increase of 2.99%.
Financial StatementsEarnings Surprise
Cencora has released their quarterly earnings on Aug 5, 2026:
- Revenue of $84.75B misses estimates by $0, with 5.07% YoY growth.
- EPS of 4.48 exceeds estimates by 0.13, with 12.00% YoY growth.
Cencora Inc. is scheduled to release its earnings on Nov 4, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2